drugset / Trial / NCT03167281

Early Intrapleural TPA Instillation Versus Late

NCT03167281

Phase 4 Withdrawn Prisma Health-Midlands
RandomizedParallel-groupOpen-labelTreatment

Summary

Chest tubes are used for air or fluid removal from the pleural space. When a chest tube is placed, it can be hard for the fluid to drain.Tissue plasminogen activator (tPA) and DNase are given through the chest tube to help with draining the fluid. We are doing this research to see if early addition of tPA-DNase immediately after chest tube placement will help with better fluid draining.

Timeline

Start
2017-02-17
Primary completion
2021-03-10
Completion
2021-03-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Alteplase Protein / enzyme biologic 10 mg Other
Subject dornase alfa Protein / enzyme biologic 5 mg Other

Indications

No indication recorded.